Private Equity
New Mountain grows life science influence with $2.45B PerkinElmer deal
August 1, 2022
New Mountain Capital has agreed to acquire multiple business divisions of PerkinElmer, a life sciences and pharmaceutical company, for $2.45 billion, marking one of the largest PE deals within the sector in recent years